Laverdia Ca1 is a drug owned by ANIVIVE LIFESCIENCES, INC. It is protected by 5 US drug patents filed in 2032. All patents are active. Details of Laverdia Ca1’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US10544108 | 26 Jul, 2032 | Active |
| US9079865 | 26 Jul, 2032 | Active |
| US9206158 | 26 Jul, 2032 | Active |
Exclusivity Information
Laverdia Ca1 holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2028. Details of Laverdia Ca1's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| ODE | Jan 11, 2028 |
About Laverdia Ca1
Laverdia Ca1 is a drug
owned by ANIVIVE LIFESCIENCES, INC.
Laverdia Ca1 uses
Verdinexor as the active
ingredient.
Active Ingredient:
Laverdia Ca1 uses
Verdinexor as the active ingredient.
Check out other Drugs and Companies using
Verdinexor ingredient.